These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26617395)

  • 1. Potential of neuropeptide Y for preventing or treating post-traumatic stress disorder.
    Sabban EL; Alaluf LG; Serova LI
    Neuropeptides; 2016 Apr; 56():19-24. PubMed ID: 26617395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular responses to intranasal neuropeptide Y in single prolonged stress rodent model of post-traumatic stress disorder.
    Camp R; Stier CT; Serova LI; McCloskey J; Edwards JG; Reyes-Zaragoza M; Sabban EL
    Neuropeptides; 2018 Feb; 67():87-94. PubMed ID: 29169656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential of Intranasal Neuropeptide Y (NPY) and/or Melanocortin 4 Receptor (MC4R) Antagonists for Preventing or Treating PTSD.
    Sabban EL; Serova LI
    Mil Med; 2018 Mar; 183(suppl_1):408-412. PubMed ID: 29635611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal neuropeptide Y reverses anxiety and depressive-like behavior impaired by single prolonged stress PTSD model.
    Serova LI; Laukova M; Alaluf LG; Pucillo L; Sabban EL
    Eur Neuropsychopharmacol; 2014 Jan; 24(1):142-7. PubMed ID: 24326087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of intranasal neuropeptide Y and HS014 in preventing anxiety and depressive-like behavior elicited by single prolonged stress.
    Sabban EL; Serova LI; Alaluf LG; Laukova M; Peddu C
    Behav Brain Res; 2015 Dec; 295():9-16. PubMed ID: 25542511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide Y, resilience, and PTSD therapeutics.
    Kautz M; Charney DS; Murrough JW
    Neurosci Lett; 2017 May; 649():164-169. PubMed ID: 27913193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single intranasal neuropeptide Y infusion attenuates development of PTSD-like symptoms to traumatic stress in rats.
    Serova LI; Tillinger A; Alaluf LG; Laukova M; Keegan K; Sabban EL
    Neuroscience; 2013 Apr; 236():298-312. PubMed ID: 23376740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Locus coeruleus response to single-prolonged stress and early intervention with intranasal neuropeptide Y.
    Sabban EL; Laukova M; Alaluf LG; Olsson E; Serova LI
    J Neurochem; 2015 Dec; 135(5):975-86. PubMed ID: 26333000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early intervention with intranasal NPY prevents single prolonged stress-triggered impairments in hypothalamus and ventral hippocampus in male rats.
    Laukova M; Alaluf LG; Serova LI; Arango V; Sabban EL
    Endocrinology; 2014 Oct; 155(10):3920-33. PubMed ID: 25057792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of intranasal administration of neuropeptide Y and single prolonged stress on food consumption and body weight in male rats.
    Serova LI; Hansson E; Sabban EL
    Neuropeptides; 2020 Aug; 82():102060. PubMed ID: 32600666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma neuropeptide Y concentrations in combat exposed veterans: relationship to trauma exposure, recovery from PTSD, and coping.
    Yehuda R; Brand S; Yang RK
    Biol Psychiatry; 2006 Apr; 59(7):660-3. PubMed ID: 16325152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential benefits of intranasal neuropeptide Y include sustained extinction of fear memory.
    Sabban EL; Serova L; Nahvi RJ; Liu X
    J Neuroendocrinol; 2023 Nov; 35(11):e13279. PubMed ID: 37157881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropeptide Y and posttraumatic stress disorder.
    Sah R; Geracioti TD
    Mol Psychiatry; 2013 Jun; 18(6):646-55. PubMed ID: 22801411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide Y (NPY) and posttraumatic stress disorder (PTSD): A translational update.
    Schmeltzer SN; Herman JP; Sah R
    Exp Neurol; 2016 Oct; 284(Pt B):196-210. PubMed ID: 27377319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex Differences in the Neuropeptide Y System and Implications for Stress Related Disorders.
    Nahvi RJ; Sabban EL
    Biomolecules; 2020 Aug; 10(9):. PubMed ID: 32867327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical findings on the potential of intranasal neuropeptide Y for treating hyperarousal features of PTSD.
    Nwokafor C; Serova LI; Sabban EL
    Ann N Y Acad Sci; 2019 Nov; 1455(1):149-159. PubMed ID: 31250475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re-exposure and environmental enrichment reveal NPY-Y1 as a possible target for post-traumatic stress disorder.
    Hendriksen H; Bink DI; Daniels EG; Pandit R; Piriou C; Slieker R; Westphal KG; Olivier B; Oosting RS
    Neuropharmacology; 2012 Sep; 63(4):733-42. PubMed ID: 22659471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum neuropeptide Y in accident survivors with depression or posttraumatic stress disorder.
    Nishi D; Hashimoto K; Noguchi H; Matsuoka Y
    Neurosci Res; 2014 Jun; 83():8-12. PubMed ID: 24709369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single prolonged stress PTSD model triggers progressive severity of anxiety, altered gene expression in locus coeruleus and hypothalamus and effected sensitivity to NPY.
    Serova LI; Nwokafor C; Van Bockstaele EJ; Reyes BAS; Lin X; Sabban EL
    Eur Neuropsychopharmacol; 2019 Apr; 29(4):482-492. PubMed ID: 30878321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central functions of neuropeptide Y in mood and anxiety disorders.
    Wu G; Feder A; Wegener G; Bailey C; Saxena S; Charney D; Mathé AA
    Expert Opin Ther Targets; 2011 Nov; 15(11):1317-31. PubMed ID: 21995655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.